A case of Fingolimod-associated Cryptococcal Meningitis

CONCLUSION: Albeit fingolimod associated cryptococcal meningitis is a rare event, Fingolimod therapy in patients with MS should be performed cautiously. Regular follow-ups may give rise to a timely diagnosis of probable fingolimod associated cryptococcal meningitis. Fingolimod therapy can lead to lymphocytopenia and various infections. We; therefore, suggest that intermittent blood lymphocyte counts as well as monitoring of clinical manifestations among MS patients treated with Fingolimod to avoid additional neurological and physical disabilities in these patients.PMID:35770404 | DOI:10.2174/1570162X20666220629124225

Source: Current HIV Research - June 30, 2022 Category: Infectious Diseases Authors: Ilad Alavi Darazam Mohammad Mahdi Rabiei Omid Moradi Farid Javandoust Gharehbagh Mehrdad Roozbeh Ramin Nourinia Firouze Hatami Maziar Shojaei Legha Lotfollahi Source Type: research